Microablative fractional radiofrequency for sexual dysfunction and vaginal Trophism: A randomized clinical trial.

ABSTRACT:

Objectives

To evaluate Microablative Fractional Radiofrequency (MAFRF) as a possible option in treating vaginal atrophy.

Methods

This was a randomized, controlled clinical trial with postmenopausal women diagnosed with vaginal atrophy. The treatment consisted of three sessions of MAFRF, compared to vaginal estrogen administration and an untreated control group. Assessments occurred at baseline and 90 days. The primary endpoints were sexual function, evaluated by the Female Sexual Function Index (FSFI), and vaginal health, assessed by the Vaginal Health Index (VHI). Secondary outcomes included vaginal microbiota composition (Nugent score) and epithelial cell maturation (Maturation Value ‒ MV).

Results

One hundred and twenty women (40 in each group) were included. Conce

SUBMITTER: Sarmento ACA 

PROVIDER: S-EPMC10589764 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature